DE602005021912D1 - Diagnose neurodegenerativer krankheiten - Google Patents
Diagnose neurodegenerativer krankheitenInfo
- Publication number
- DE602005021912D1 DE602005021912D1 DE602005021912T DE602005021912T DE602005021912D1 DE 602005021912 D1 DE602005021912 D1 DE 602005021912D1 DE 602005021912 T DE602005021912 T DE 602005021912T DE 602005021912 T DE602005021912 T DE 602005021912T DE 602005021912 D1 DE602005021912 D1 DE 602005021912D1
- Authority
- DE
- Germany
- Prior art keywords
- swissprot acc
- acc
- protein
- swissprot
- precursor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000003745 diagnosis Methods 0.000 title abstract 2
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 abstract 5
- 108090000623 proteins and genes Proteins 0.000 abstract 5
- 239000002243 precursor Substances 0.000 abstract 4
- 102000007469 Actins Human genes 0.000 abstract 1
- 108010085238 Actins Proteins 0.000 abstract 1
- 102100037320 Apolipoprotein A-IV Human genes 0.000 abstract 1
- 102000021944 Butyrylcholinesterase Human genes 0.000 abstract 1
- 108010053652 Butyrylcholinesterase Proteins 0.000 abstract 1
- 102100025406 Complement C1s subcomponent Human genes 0.000 abstract 1
- 102400000143 Haptoglobin beta chain Human genes 0.000 abstract 1
- 101800001341 Haptoglobin beta chain Proteins 0.000 abstract 1
- 101000934958 Homo sapiens Complement C1s subcomponent Proteins 0.000 abstract 1
- 101000961149 Homo sapiens Immunoglobulin heavy constant gamma 4 Proteins 0.000 abstract 1
- 108060003951 Immunoglobulin Proteins 0.000 abstract 1
- 102100039347 Immunoglobulin heavy constant gamma 4 Human genes 0.000 abstract 1
- 102000011681 Lumican Human genes 0.000 abstract 1
- 108010076371 Lumican Proteins 0.000 abstract 1
- 108091005804 Peptidases Proteins 0.000 abstract 1
- 239000004365 Protease Substances 0.000 abstract 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 abstract 1
- 208000018756 Variant Creutzfeldt-Jakob disease Diseases 0.000 abstract 1
- 102000015395 alpha 1-Antitrypsin Human genes 0.000 abstract 1
- 108010050122 alpha 1-Antitrypsin Proteins 0.000 abstract 1
- 229940024142 alpha 1-antitrypsin Drugs 0.000 abstract 1
- 108010073614 apolipoprotein A-IV Proteins 0.000 abstract 1
- 230000000295 complement effect Effects 0.000 abstract 1
- 230000003247 decreasing effect Effects 0.000 abstract 1
- 229940012952 fibrinogen Drugs 0.000 abstract 1
- 102000018358 immunoglobulin Human genes 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 239000003550 marker Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2828—Prion diseases
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/56—Staging of a disease; Further complications associated with the disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medical Treatment And Welfare Office Work (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0426859.5A GB0426859D0 (en) | 2004-12-07 | 2004-12-07 | Diagnosis of neurodegenerative disorders |
| GBGB0521762.5A GB0521762D0 (en) | 2004-12-07 | 2005-10-25 | Diagnosis of neurodegenerative disorders |
| PCT/GB2005/004698 WO2006061609A2 (en) | 2004-12-07 | 2005-12-07 | Diagnosis of neurodegenerative diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE602005021912D1 true DE602005021912D1 (de) | 2010-07-29 |
Family
ID=34073345
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE602005017819T Active DE602005017819D1 (de) | 2004-12-07 | 2005-12-07 | Monitorierung von Huntington's Disease |
| DE602005021912T Active DE602005021912D1 (de) | 2004-12-07 | 2005-12-07 | Diagnose neurodegenerativer krankheiten |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE602005017819T Active DE602005017819D1 (de) | 2004-12-07 | 2005-12-07 | Monitorierung von Huntington's Disease |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US9028801B2 (de) |
| AT (2) | ATE471519T1 (de) |
| DE (2) | DE602005017819D1 (de) |
| ES (2) | ES2333892T3 (de) |
| GB (2) | GB0426859D0 (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101978269A (zh) | 2008-01-18 | 2011-02-16 | 哈佛大学校长及研究员协会 | 在体液中检测疾病或病症标志的方法 |
| EA201390150A1 (ru) | 2010-07-23 | 2013-09-30 | Президент Энд Феллоуз Оф Гарвард Колледж | Способы выявления сигнатур заболевания или патологических состояний в текучих средах организма |
| MX2013000917A (es) | 2010-07-23 | 2013-07-05 | Harvard College | Metodos para detectar las enfermedades o condiciones usando celulas fagociticas. |
| CA2806304A1 (en) | 2010-07-23 | 2012-01-26 | President And Fellows Of Harvard College | Methods of detecting prenatal or pregnancy-related diseases or conditions |
| WO2012012694A2 (en) | 2010-07-23 | 2012-01-26 | President And Fellows Of Harvard College | Methods of detecting autoimmune or immune-related diseases or conditions |
| EP2592421B1 (de) * | 2011-11-14 | 2017-08-30 | Universitätsklinikum Jena | Diagnose von blutvergiftung und des systemischen entzündungsreaktionssyndroms |
| EA201590024A1 (ru) | 2012-06-15 | 2015-05-29 | Гарри Стилли | Способы определения заболеваний или состояний с применением циркулирующих болезненных клеток |
| WO2013188846A1 (en) | 2012-06-15 | 2013-12-19 | Harry Stylli | Methods of detecting diseases or conditions |
| EP3385717A3 (de) | 2013-03-09 | 2018-10-24 | Harry Stylli | Verfahren zum nachweis von prostatakrebs |
| WO2014164366A1 (en) | 2013-03-09 | 2014-10-09 | Harry Stylli | Methods of detecting cancer |
| EP4075139B1 (de) | 2014-09-11 | 2024-05-22 | Immunis.AI, Inc. | Verfahren zum nachweis von prostatakrebs |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6824988B2 (en) | 2000-05-15 | 2004-11-30 | R.E.D. Laboratories, N.V. | Method and compositions for use in diagnosing and characterizing chronic immune disease |
| GB0026604D0 (en) * | 2000-10-31 | 2000-12-13 | Roslin Inst Edinburgh | Diagnostic method |
| CA2591926A1 (en) * | 2004-09-20 | 2006-03-30 | Proteogenix, Inc. | Diagnosis of fetal aneuploidy |
| GB0421639D0 (en) * | 2004-09-29 | 2004-10-27 | Proteome Sciences Plc | Methods and compositions relating to alzheimer's disease |
| US7704708B2 (en) * | 2006-02-13 | 2010-04-27 | Uti Limited Partnership | Monomeric streptavidin muteins |
-
2004
- 2004-12-07 GB GBGB0426859.5A patent/GB0426859D0/en not_active Ceased
-
2005
- 2005-10-25 GB GBGB0521762.5A patent/GB0521762D0/en not_active Ceased
- 2005-12-07 US US11/792,686 patent/US9028801B2/en not_active Expired - Fee Related
- 2005-12-07 DE DE602005017819T patent/DE602005017819D1/de active Active
- 2005-12-07 ES ES05820667T patent/ES2333892T3/es active Active
- 2005-12-07 AT AT05823285T patent/ATE471519T1/de not_active IP Right Cessation
- 2005-12-07 US US11/792,758 patent/US8506957B2/en not_active Expired - Fee Related
- 2005-12-07 ES ES05823285T patent/ES2344118T3/es active Active
- 2005-12-07 AT AT05820667T patent/ATE449345T1/de not_active IP Right Cessation
- 2005-12-07 DE DE602005021912T patent/DE602005021912D1/de active Active
Also Published As
| Publication number | Publication date |
|---|---|
| DE602005017819D1 (de) | 2009-12-31 |
| ATE471519T1 (de) | 2010-07-15 |
| US8506957B2 (en) | 2013-08-13 |
| ES2333892T3 (es) | 2010-03-02 |
| US9028801B2 (en) | 2015-05-12 |
| ES2344118T3 (es) | 2010-08-18 |
| GB0426859D0 (en) | 2005-01-12 |
| US20080213802A1 (en) | 2008-09-04 |
| GB0521762D0 (en) | 2005-11-30 |
| US20080286263A1 (en) | 2008-11-20 |
| ATE449345T1 (de) | 2009-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602005021912D1 (de) | Diagnose neurodegenerativer krankheiten | |
| WO2006061609A3 (en) | Diagnosis of neurodegenerative diseases | |
| Osbourn et al. | HpARI protein secreted by a helminth parasite suppresses interleukin-33 | |
| ES2406266T3 (es) | Antígeno CD14 soluble novedoso | |
| WO2005016127A3 (en) | Prion-specific peptide reagents | |
| WO2006086799A3 (en) | Prion-specific peptide reagents | |
| FR21C1004I2 (fr) | Utilisation de la proteinase ides (de s. pyogenes) pour le traitement des maladies autoimmunes et du rejet de greffe | |
| CY2016039I1 (el) | Χιμαιρικες πρωτεϊνες παραγοντα πηξης για την αγωγη αιμοστατικων ασθενειων | |
| ATE517922T1 (de) | Stabilisierte einzel-domänen-antikörper in einer pharmazeutischen zusammensetzung ausgestaltet für inhalation | |
| WO2007068985A3 (en) | Diagnosis and prognosis of colorectal cancer | |
| WO2008008482A3 (en) | Altered br3-binding polypeptides | |
| WO2008055491A3 (de) | Diagnose und risikostratifizierung von diabetes mellitus mittels mr-proadm | |
| WO2008071418A3 (en) | Use of the endoglycosidase endos for treating immunoglobulin g mediated diseases | |
| WO2008122670A3 (en) | Human diabetes susceptibility tnfrsf10b gene | |
| WO2002032461A3 (en) | Protein c or activated protein c-like molecules | |
| WO2005016132A3 (en) | Diagnostics for sars virus | |
| WO2005056585A3 (en) | Sars coronavirus s proteins and uses thereof | |
| DK2044125T3 (da) | Sammensætninger og fremgangsmåder til indgivelse af aktiverede anti-ras-antistoffer i celler | |
| AU2002341090A1 (en) | Use of a protein of the crmp family for treating diseases related to the immune system | |
| Parambeth et al. | Purification and partial characterization of α1-proteinase inhibitor in the common marmoset (Callithrix jacchus) | |
| WO2004007555A3 (en) | Detection of prion disease | |
| WO2004113386A3 (en) | Modified hirudin proteins and t-cell epitopes in hirudin | |
| WO2004099251A3 (en) | Compositions and methods for treatment of cryptococcosis | |
| WO2005005471A3 (en) | Use of dg153 secreted protein products for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome | |
| WO2007084236A3 (en) | Human gene associated with diabetic retinopathy |